Pathology of Immune-Mediated Liver Injury

被引:51
|
作者
Dienes, Hans-Peter [1 ]
Drebber, Uta [1 ]
机构
[1] Univ Cologne, Inst Pathol, DE-50924 Cologne, Germany
关键词
Toxic liver injury; Histopathology; Histopathology of viral hepatitis; Histology of autoimmune liver disease; HEPATITIS-C VIRUS; AUTOIMMUNE HEPATITIS; T-CELLS; B VIRUS; CLEARANCE; DISEASE;
D O I
10.1159/000282065
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The liver is a special lymphoid organ with its own defense mechanism and it is prone to chronic viral and autoimmune diseases. All constituent liver cells are involved in immune mechanisms against foreign toxins and infectious agents: hepatocytes, Kupffer cells, endothelial cells, hepatic stellate cells and liver resident lymphocytes such as natural killer, natural killer T and dendritic cells. The first line of defense is held up by the innate immune system where the adaptive immune response is more antigen-specific, but needs a longer time to build up. Even in drug injury of the liver, the innate immune system is involved. There is activation of natural killer and natural killer T cells, and liver cell damage is induced mainly by the Fas and FasL pathways. In viral hepatitis, the mechanism of liver injury is mainly immune-mediated since almost none of the hepatitis viruses have turned out to be cytopathic by themselves. Cytotoxic T lymphocytes with CD8 epitopes are the most important effector cell population. The immune defense may be downregulated by regulatory T cell lymphocytes, PD1/PDL-positive lymphocytes or suppressor dendritic cells. In Epstein-Barr virus infection, liver cell injury does not seem to be due to direct antigen-specific CTLs, but the injury is assumingly induced by a bystander reaction from activated lymphocytes in the sinusoids. Autoimmune hepatitis is a paradigm of immune-mediated liver injury and has a special, but not pathognomonic, histopathology. The main effector lymphocytes belong to the CD8 population, which are antigen-specific; however, the mechanisms seem to be suppressed by regulatory T cells. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:57 / 62
页数:6
相关论文
共 50 条
  • [31] Effect of Plaferon LB on oxidative stress in liver tissue in immune-mediated liver injury
    Chikovani, T
    Sanikidze, T
    Sharashenidze, T
    Cheishvili, N
    Bakhutashvili, V
    [J]. ALLERGY, 2002, 57 : 71 - 71
  • [32] MECHANISMS OF IMMUNE-MEDIATED MYOCYTE INJURY
    BARRY, WH
    [J]. CIRCULATION, 1994, 89 (05) : 2421 - 2432
  • [33] Immune-mediated injury of motoneurons in ALS
    Appel, SH
    Siklos, L
    Alexianu, M
    Colom, L
    Ho, BK
    Mohamed, AH
    Mosier, D
    Smith, RG
    [J]. AMYOTROPHIC LATERAL SCLEROSIS: PROGRESS AND PERSPECTIVES IN BASIC RESEARCH AND CLINICAL APPLICATION, 1996, 1104 : 184 - 191
  • [34] EICOSANOIDS IN IMMUNE-MEDIATED RENAL INJURY
    LIANOS, EA
    [J]. SEMINARS IN NEPHROLOGY, 1992, 12 (05) : 441 - 453
  • [35] Apoptosis in Immune-Mediated Liver Diseases
    Kahraman, Alisan
    Gerken, Guido
    Canbay, Ali
    [J]. DIGESTIVE DISEASES, 2010, 28 (01) : 144 - 149
  • [36] Immune-Mediated Therapies for Liver Cancer
    Aravalli, Rajagopal N.
    Steer, Clifford J.
    [J]. GENES, 2017, 8 (02):
  • [37] Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors
    Fontana, Robert J.
    Li, Yi-Ju
    Chen, Vincent
    Kleiner, David
    Stolz, Andrew
    Odin, Joe
    Vuppalanchi, Raj
    Gu, Jiezhun
    Dara, Lily
    Barnhart, Huiman
    [J]. HEPATOLOGY COMMUNICATIONS, 2024, 8 (09)
  • [38] ISONIAZID-INDUCED LIVER INJURY IN HUMANS IS IMMUNE-MEDIATED AND NOT "METABOLIC IDIOSYNCRASY"
    Metushi, Imir G.
    Uetrecht, Jack P.
    [J]. DRUG METABOLISM REVIEWS, 2014, 45 : 48 - 49
  • [39] Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice
    Sass, G
    Koerber, K
    Bang, R
    Guehring, H
    Tiegs, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04): : 439 - 447
  • [40] Suppression of immune-mediated liver injury after vaccination with attenuated pathogenic cells
    Mei, Yunhua
    Wang, Ying
    Xu, Lingyun
    [J]. IMMUNOLOGY LETTERS, 2007, 110 (01) : 29 - 35